Exact Mass: 333.2519

Exact Mass Matches: 333.2519

Found 142 metabolites which its exact mass value is equals to given mass value 333.2519, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Mahanimbinol

1-[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9H-carbazol-2-ol

C23H27NO (333.2093)


Mahanimbinol is found in herbs and spices. Mahanimbinol is an alkaloid from Murraya koenigii (curryleaf tree). Alkaloid from Murraya koenigii (curryleaf tree). Mahanimbinol is found in herbs and spices.

   

Deptropine

8-methyl-3-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-yloxy}-8-azabicyclo[3.2.1]octane

C23H27NO (333.2093)


Deptropine is a tricyclic H1-antihistamine.

   

2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine

2-(4-{2-[4-(2,2-dimethylbutyl)-3H-imidazol-2-yl]ethyl}phenyl)pyridine

C22H27N3 (333.2205)


   

Carbetapentane

2-[2-(diethylamino)Ethoxy]ethyl 1-phenylcyclopentane-1-carboxylic acid

C20H31NO3 (333.2304)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membran σ1, respectively. Pentoxyverine is a muscarinic antagonist. Pentoxyverine is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].

   

Ethyl 2-[2-(diethylamino)ethoxy]-1-phenylcyclopentane-1-carboxylate

Ethyl 2-[2-(diethylamino)ethoxy]-1-phenylcyclopentane-1-carboxylic acid

C20H31NO3 (333.2304)


   

Malonganenone C

Malonganenone C

C21H35NO2 (333.2668)


   

Eustifoline C

Eustifoline C

C23H27NO (333.2093)


   

4-[(6E)-3-Hydroxy-8,10-dimethyl-2-(methylamino)-6-dodecen-1-yl]phenol

4-[(6E)-3-Hydroxy-8,10-dimethyl-2-(methylamino)-6-dodecen-1-yl]phenol

C21H35NO2 (333.2668)


   

Stearidonoyl glycine

2-(6Z,9Z,12Z,15Z)-octadeca-tetraenamidoacetic acid

C20H31NO3 (333.2304)


   

mahanimbilol

mahanimbilol

C23H27NO (333.2093)


   
   
   

Malonganenone K|N-[(2E,6E,10E)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,10-trien-1-yl]formamide

Malonganenone K|N-[(2E,6E,10E)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,10-trien-1-yl]formamide

C21H35NO2 (333.2668)


   

karapinchamine A

karapinchamine A

C23H27NO (333.2093)


   

Mahanimbine

Mahanimbine

C23H27NO (333.2093)


   
   
   
   

Pentoxyverine

carbetapentane

C20H31NO3 (333.2304)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membran σ1, respectively. Pentoxyverine is a muscarinic antagonist. Pentoxyverine is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].

   

4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol

NCGC00380664-01!4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol

C21H35NO2 (333.2668)


   

4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol

4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol

C21H35NO2 (333.2668)


   

4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol [IIN-based on: CCMSLIB00000847532]

NCGC00380664-01!4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol [IIN-based on: CCMSLIB00000847532]

C21H35NO2 (333.2668)


   

4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol [IIN-based: Match]

NCGC00380664-01!4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol [IIN-based: Match]

C21H35NO2 (333.2668)


   

carbetapentane

carbetapentane

C20H31NO3 (333.2304)


   

Mahanimbinol

1-[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9H-carbazol-2-ol

C23H27NO (333.2093)


   

Docosahexaenoic Acid-d5

Docosahexaenoic Acid-d5

C22H27D5O2 (333.2716)


   

DHA (d5)

4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid (d5)

C22H27D5O2 (333.2716)


   
   

tert-butyl N-[[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]carbamate

tert-butyl N-[[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]carbamate

C18H28BNO4 (333.2111)


   

Saxagliptin hydrate

Saxagliptin hydrate

C18H27N3O3 (333.2052)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

2,4,6-TRI-TERT-BUTYL-N-(TRIMETHYLSILYL)ANILINE

2,4,6-TRI-TERT-BUTYL-N-(TRIMETHYLSILYL)ANILINE

C21H39NSi (333.2852)


   

N-(2-(dimethylamino)ethyl)-N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide

N-(2-(dimethylamino)ethyl)-N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide

C17H28BN3O3 (333.2224)


   

(S)-(-)-2-(3 5-DI-TERT-BUTYLSALICYLIDEN&

(S)-(-)-2-(3 5-DI-TERT-BUTYLSALICYLIDEN&

C21H35NO2 (333.2668)


   

3,3-(dodecylimino)bispropane-1,2-diol

3,3-(dodecylimino)bispropane-1,2-diol

C18H39NO4 (333.2879)


   

4-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine

4-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine

C18H28BNO4 (333.2111)


   

11-aminoundecyltriethoxysilane

11-aminoundecyltriethoxysilane

C17H39NO3Si (333.2699)


   

2-(2-Morpholinoethylamino)pyridine-5-boronic acid pinacol ester

2-(2-Morpholinoethylamino)pyridine-5-boronic acid pinacol ester

C17H28BN3O3 (333.2224)


   

N-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclohexanamine

N-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclohexanamine

C19H29BFNO2 (333.2275)


   

tert-Butyl 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate

tert-Butyl 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate

C18H28BNO4 (333.2111)


   

tert-Butyl 2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate

tert-Butyl 2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate

C18H28BNO4 (333.2111)


   

4-Cyano-4-undecylbiphenyl

4-Cyano-4-undecylbiphenyl

C24H31N (333.2456)


   

TERT-BUTYL4-(2-METHYL-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL4-(2-METHYL-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE

C18H27N3O3 (333.2052)


   

4-(2-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxy]-ethyl)-morpholine

4-(2-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxy]-ethyl)-morpholine

C18H28BNO4 (333.2111)


   

trans-4-[5-(4-Pentylcyclohexyl)-2-pyrimidinyl]benzonitrile

trans-4-[5-(4-Pentylcyclohexyl)-2-pyrimidinyl]benzonitrile

C22H27N3 (333.2205)


   

(2,6-DIOXO-3,6-DIHYDROPYRIMIDIN-1(2H)-YL)ACETICACID

(2,6-DIOXO-3,6-DIHYDROPYRIMIDIN-1(2H)-YL)ACETICACID

C18H27N3O3 (333.2052)


   

bis(2-hydroxyethyl)ammonium myristate

bis(2-hydroxyethyl)ammonium myristate

C18H39NO4 (333.2879)


   

4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine

4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine

C18H28BNO4 (333.2111)


   

N-(4-FLUORO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)CYCLOHEXANAMINE

N-(4-FLUORO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)CYCLOHEXANAMINE

C19H29BFNO2 (333.2275)


   

TERT-BUTYL 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYLCARBAMATE

TERT-BUTYL 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYLCARBAMATE

C18H28BNO4 (333.2111)


   

17-Desacetyl Norgestimate-d6 (Mixture of Isomers)

17-Desacetyl Norgestimate-d6 (Mixture of Isomers)

C21H23D6NO2 (333.2575)


   

Saxagliptin Impurity 15

Saxagliptin Impurity 15

C18H27N3O3 (333.2052)


   

4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide

4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide

C18H27N3O3 (333.2052)


   

N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one

N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one

C19H31NO2Si (333.2124)


   

3-((n-boc-amino)methyl)phenylboronic acid

3-((n-boc-amino)methyl)phenylboronic acid

C18H28BNO4 (333.2111)


   

octyl 2-acetamido-2-deoxy-b-d-glucopyranoside

octyl 2-acetamido-2-deoxy-b-d-glucopyranoside

C16H31NO6 (333.2151)


   

tert-butyl N-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbamate

tert-butyl N-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbamate

C18H28BNO4 (333.2111)


   

1-METHYL-2,5-BIS(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE

1-METHYL-2,5-BIS(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE

C17H29B2NO4 (333.2283)


   

Isomylamine hydrochloride

Isomylamine hydrochloride

C18H36ClNO2 (333.2434)


C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

   

2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine

2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine

C22H27N3 (333.2205)


   

deptropine

Dibenzheptropine

C23H27NO (333.2093)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

(5S,6E,8Z,11Z,14Z,16E,18R)-5,18-dihydroxyicosa-6,8,11,14,16-pentaenoate

(5S,6E,8Z,11Z,14Z,16E,18R)-5,18-dihydroxyicosa-6,8,11,14,16-pentaenoate

C20H29O4- (333.2066)


   

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oate

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oate

C20H29O4- (333.2066)


   

(5Z,13E,15S)-15-hydroxy-11-oxoprosta-5,9,13-trien-1-oate

(5Z,13E,15S)-15-hydroxy-11-oxoprosta-5,9,13-trien-1-oate

C20H29O4- (333.2066)


   

octyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside

octyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside

C16H31NO6 (333.2151)


   

15-dehydroprostaglandin B1

15-dehydroprostaglandin B1

C20H29O4- (333.2066)


   

(7R,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate

(7R,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate

C20H29O4- (333.2066)


   

(7S,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate

(7S,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate

C20H29O4- (333.2066)


   

(7E,9E,11Z,13E,15R)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate

(7E,9E,11Z,13E,15R)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate

C20H29O4- (333.2066)


   

(7E,9E,11Z,13E,15S)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate

(7E,9E,11Z,13E,15S)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate

C20H29O4- (333.2066)


   

Ent-6alpha, 7alpha-dihydroxykaur-16-en-19-oate

Ent-6alpha, 7alpha-dihydroxykaur-16-en-19-oate

C20H29O4- (333.2066)


   

(5S,18S)-dihydroxy-(6E,8Z,11Z,14Z,16E)-eicosapentaenoate

(5S,18S)-dihydroxy-(6E,8Z,11Z,14Z,16E)-eicosapentaenoate

C20H29O4- (333.2066)


   

1-(2-{4-[(4-Carboxybutanoyl)amino]phenyl}ethyl)-1-methylpiperidinium

1-(2-{4-[(4-Carboxybutanoyl)amino]phenyl}ethyl)-1-methylpiperidinium

C19H29N2O3+ (333.2178)


   

5,20-diHEPE(1-)

5,20-diHEPE(1-)

C20H29O4- (333.2066)


An icosanoid anion that is the conjugate base of 5,20-di-HEPE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

12(S)-HpEPE(1-)

12(S)-HpEPE(1-)

C20H29O4- (333.2066)


A 12-HPEPE anion that is the conjugate base of 12(S)-HpEPE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

15-dehydroprostaglandin A1(1-)

15-dehydroprostaglandin A1(1-)

C20H29O4- (333.2066)


A prostaglandin carboxylic acid anion that is the conjugate base of 15-dehydro-prostaglandin A1, obtained by deprotonation of the carboxy group.; major species at pH 7.3.

   

12-Hpepe(1-)

12-Hpepe(1-)

C20H29O4- (333.2066)


A polyunsaturated fatty acid anion that is the conjugate base of 12-HPEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Tert-butyl 2-[3-(mesitylamino)-1-methyl-3-oxopropylidene]hydrazinecarboxylate

Tert-butyl 2-[3-(mesitylamino)-1-methyl-3-oxopropylidene]hydrazinecarboxylate

C18H27N3O3 (333.2052)


   

12-oxo-Leukotriene B4

12-oxo-Leukotriene B4

C20H29O4- (333.2066)


   

soppiline A anion

soppiline A anion

C21H33O3- (333.243)


   

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,8(12),13-trien-1-oate

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,8(12),13-trien-1-oate

C20H29O4- (333.2066)


   

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,11,13-trien-1-oate

(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,11,13-trien-1-oate

C20H29O4- (333.2066)


   
   

(5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate

(5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate

C20H29O4- (333.2066)


   

(5Z,8R,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate

(5Z,8R,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate

C20H29O4- (333.2066)


   

(5Z,12E,15S)-15-hydroxy-11-oxoprosta-5,9,12-trien-1-oate

(5Z,12E,15S)-15-hydroxy-11-oxoprosta-5,9,12-trien-1-oate

C20H29O4- (333.2066)


   

(5S,6E,8E,10E,14Z)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoate

(5S,6E,8E,10E,14Z)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoate

C20H29O4- (333.2066)


   

N-(2-hydroxyethyl)nonadeca-7,10,13,16-tetraenamide

N-(2-hydroxyethyl)nonadeca-7,10,13,16-tetraenamide

C21H35NO2 (333.2668)


   

1-(5-Methyl-2-propan-2-ylcyclohexyl)oxy-3-(1-phenylethylamino)-2-propanol

1-(5-Methyl-2-propan-2-ylcyclohexyl)oxy-3-(1-phenylethylamino)-2-propanol

C21H35NO2 (333.2668)


   

(10Z,13Z,16Z)-docosatrienoate

(10Z,13Z,16Z)-docosatrienoate

C22H37O2- (333.2793)


A long-chain polyunsaturated fatty acid anion that is the conjugate base of (10Z,13Z,16Z)-docosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(13Z,16Z,19Z)-Docosatrienoate

(13Z,16Z,19Z)-Docosatrienoate

C22H37O2- (333.2793)


A long-chain polyunsaturated fatty acid anion that is the conjugate base of (13Z,16Z,19Z)-docosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

(5S,6Z,8E,10E,12R,14Z,17Z)-5,12-dihydroxyicosa-6,8,10,14,17-pentaenoate

(5S,6Z,8E,10E,12R,14Z,17Z)-5,12-dihydroxyicosa-6,8,10,14,17-pentaenoate

C20H29O4- (333.2066)


   

5(S)-HpEPE(1-)

5(S)-HpEPE(1-)

C20H29O4- (333.2066)


   

14-oxo-15-hydroxy-(5Z,8Z,11Z,17Z)-eicosatetraenoate

14-oxo-15-hydroxy-(5Z,8Z,11Z,17Z)-eicosatetraenoate

C20H29O4- (333.2066)


   

(15S)-hydroperoxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate

(15S)-hydroperoxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate

C20H29O4- (333.2066)


   
   

Picolinyl pentadecanoate

Picolinyl pentadecanoate

C21H35NO2 (333.2668)


   

1,3-Di-O-trimethylsilyl decasphinganine

1,3-Di-O-trimethylsilyl decasphinganine

C16H39NO2Si2 (333.2519)


   

5-(2-(6-Methyl-3-pyridyl)ethyl)-2-propyl-1,2,3,4-tetrahydro-gamma-carboline

5-(2-(6-Methyl-3-pyridyl)ethyl)-2-propyl-1,2,3,4-tetrahydro-gamma-carboline

C22H27N3 (333.2205)


   

2-(4-(8-Chloro-3,7-dimethylocta-2(E),6(E)-dienyl)-1,3,3-trimethyl-1-cyclohexen-2-YL)acetonitrile

2-(4-(8-Chloro-3,7-dimethylocta-2(E),6(E)-dienyl)-1,3,3-trimethyl-1-cyclohexen-2-YL)acetonitrile

C21H32ClN (333.2223)


   

prostaglandin J2(1-)

prostaglandin J2(1-)

C20H29O4 (333.2066)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin J2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(18S)-resolvin E2(1-)

(18S)-resolvin E2(1-)

C20H29O4 (333.2066)


An icosanoid anion that is the conjugate base of (18S)-resolvin E2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

soppiline A(1-)

soppiline A(1-)

C21H33O3 (333.243)


A hydroxy monocarboxylic acid anion that is the conjugate base of soppiline A, arising from the deprotonation of the carboxy group. Major species at pH 7.3.

   

prostaglandin B2(1-)

prostaglandin B2(1-)

C20H29O4 (333.2066)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin B2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin C2(1-)

prostaglandin C2(1-)

C20H29O4 (333.2066)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin C2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

leukotriene B5(1-)

leukotriene B5(1-)

C20H29O4 (333.2066)


An icosanoid anion that is the conjugate base of leukotriene B5, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Docosatrienoate

Docosatrienoate

C22H37O2 (333.2793)


A polyunsaturated fatty acid anion containing 22 carbons and 3 double bonds. Major species at pH 7.3.

   

resolvin E2(1-)

resolvin E2(1-)

C20H29O4 (333.2066)


A polyunsaturated fatty acid anion that is the conjugate base of resolvin E2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin A2(1-)

prostaglandin A2(1-)

C20H29O4 (333.2066)


A prostaglandin carboxylic acid anion resulting from the removal of the proton from the carboxy group of prostaglandin A2.

   

NA-Gly 18:4(6Z,9Z,12Z,15Z)

NA-Gly 18:4(6Z,9Z,12Z,15Z)

C20H31NO3 (333.2304)


   

NA-Histamine 15:1(9Z)

NA-Histamine 15:1(9Z)

C20H35N3O (333.278)


   
   
   

4-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-9h-carbazol-3-ol

4-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-9h-carbazol-3-ol

C23H27NO (333.2093)


   

2-[(1-hydroxy-2-methylbutylidene)amino]-n-(2-phenylethyl)pentanediimidic acid

2-[(1-hydroxy-2-methylbutylidene)amino]-n-(2-phenylethyl)pentanediimidic acid

C18H27N3O3 (333.2052)


   

(5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

(5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

C20H31NO3 (333.2304)


   

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1r,2r)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1r,2r)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

(1s,16s,19r)-19-isopropyl-13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

(1s,16s,19r)-19-isopropyl-13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

C23H27NO (333.2093)


   

n-(3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl)methanimidic acid

n-(3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl)methanimidic acid

C21H35NO2 (333.2668)


   

(2s)-2-{[(2r)-1-hydroxy-2-methylbutylidene]amino}-n-(2-phenylethyl)pentanediimidic acid

(2s)-2-{[(2r)-1-hydroxy-2-methylbutylidene]amino}-n-(2-phenylethyl)pentanediimidic acid

C18H27N3O3 (333.2052)


   

n-[2-(4-hydroxyphenyl)ethyl]-3-methyldodecanimidic acid

n-[2-(4-hydroxyphenyl)ethyl]-3-methyldodecanimidic acid

C21H35NO2 (333.2668)


   

(1e,5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

(1e,5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

C20H31NO3 (333.2304)


   

4-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazol-3-ol

4-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazol-3-ol

C23H27NO (333.2093)


   

(3s,4as,11br)-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-4ah,11h,11bh-pyrano[3,2-a]carbazole

(3s,4as,11br)-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-4ah,11h,11bh-pyrano[3,2-a]carbazole

C23H27NO (333.2093)


   

4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazol-3-ol

4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazol-3-ol

C23H27NO (333.2093)


   

3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-4ah,11h,11bh-pyrano[3,2-a]carbazole

3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-4ah,11h,11bh-pyrano[3,2-a]carbazole

C23H27NO (333.2093)


   

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9h-carbazol-2-ol

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9h-carbazol-2-ol

C23H27NO (333.2093)


   

1-(3,7-dimethylocta-1,6-dien-1-yl)-3-methyl-9h-carbazol-2-ol

1-(3,7-dimethylocta-1,6-dien-1-yl)-3-methyl-9h-carbazol-2-ol

C23H27NO (333.2093)


   

(3s)-n-[2-(4-hydroxyphenyl)ethyl]-3-methyldodecanimidic acid

(3s)-n-[2-(4-hydroxyphenyl)ethyl]-3-methyldodecanimidic acid

C21H35NO2 (333.2668)


   

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1s,2s)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1s,2s)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

n-[(2e,6e,11z)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl]methanimidic acid

n-[(2e,6e,11z)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl]methanimidic acid

C21H35NO2 (333.2668)


   

1-[(1e,3s)-3,7-dimethylocta-1,6-dien-1-yl]-3-methyl-9h-carbazol-2-ol

1-[(1e,3s)-3,7-dimethylocta-1,6-dien-1-yl]-3-methyl-9h-carbazol-2-ol

C23H27NO (333.2093)


   

19-isopropyl-13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

19-isopropyl-13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

C23H27NO (333.2093)


   

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

2,2,2-trifluoro-1-(2-methyl-3-undecyl-4,5-dihydropyrrol-1-yl)ethanone

2,2,2-trifluoro-1-(2-methyl-3-undecyl-4,5-dihydropyrrol-1-yl)ethanone

C18H30F3NO (333.2279)


   

n-[(2e,6e,11e)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl]methanimidic acid

n-[(2e,6e,11e)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl]methanimidic acid

C21H35NO2 (333.2668)


   

1-[(1r,3ar,3br,9as,9bs,11ar)-7-amino-3a-hydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]ethanone

1-[(1r,3ar,3br,9as,9bs,11ar)-7-amino-3a-hydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]ethanone

C21H35NO2 (333.2668)


   

1-(3,7-dimethylocta-2,6-dien-1-yl)-3-methyl-9h-carbazol-2-ol

1-(3,7-dimethylocta-2,6-dien-1-yl)-3-methyl-9h-carbazol-2-ol

C23H27NO (333.2093)